Home » Topics » Regulatory

Regulatory
RSS

Xeloda approved in E.U. as adjuvant therapy for colon cancer

April 1, 2005

Once-monthly Boniva receives FDA approval

March 31, 2005

Depo-subQ provera 104 approved for management of endometriosis pain

March 31, 2005

Baraclude receives FDA approval

March 31, 2005

Colombian approval for Impavido for cutaneous leishmaniasis

March 29, 2005

Abilify receives new approval

March 9, 2005

Clarinex-D 24 Hour receives FDA approval

March 8, 2005

Controlled release formulations for antiinfective therapy claimed

March 4, 2005

Advitech and the CHULRC to test XP-828L for inflammatory bowel diseases

March 1, 2005

New indications for procarbazine hydrochloride in Japan

March 1, 2005

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...